Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lotta Larsson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Arthritis and Rheumatism|October 1, 2004
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et alTore Saxne, Lotta Larsson, Pierre Geborek
Chemosphere|January 30, 2007
Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47Per Ola Darnerud, Marie Aune, Lotta Larsson, et al.
BMC Pregnancy and Childbirth|January 24, 2018
"You just need to leave the room when you breastfeed" Breastfeeding experiences among obese women in Sweden - A qualitative studyIng-Marie Claesson, Lotta Larsson, Linda Steen, et al.
Archives of Public Health = Archives Belges De Sante Publique|May 2, 2021
The physical and mental impact of surviving sepsis - a qualitative study of experiences and perceptions among a Swedish sampleSabine Apitzsch, Lotta Larsson, Anna-Karin Larsson, et al.
Arthritis Research & Therapy|June 26, 2003
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanerceptMeliha Crnkic, Bengt Månsson, Lotta Larsson, et al.
Ugeskrift for Laeger|February 7, 2007
[Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication]Klaus Bendtzen, Pierre Geborek, Morten Svenson, et al.
Arthritis and Rheumatism|November 30, 2006
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximabKlaus Bendtzen, Pierre Geborek, Morten Svenson, et al.
Arthritis Research & Therapy|July 28, 2006
Predictors of infusion reactions during infliximab treatment in patients with arthritisMeliha C Kapetanovic, Lotta Larsson, Lennart Truedsson, et al.
The Science of the Total Environment|June 29, 2011
Levels of brominated flame retardants and other pesistent organic pollutants in breast milk samples from Limpopo Province, South AfricaPer Ola Darnerud, Marie Aune, Lotta Larsson, et al.
Lakartidningen|October 2, 2024
[Dementia in Down syndrome]Ann-Charlotte Granholm, Lotta Larsson, Fredrik Öhman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Arthritis and Rheumatism|October 1, 2004
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et alTore Saxne, Lotta Larsson, Pierre Geborek
Chemosphere|January 30, 2007
Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47Per Ola Darnerud, Marie Aune, Lotta Larsson, et al.
BMC Pregnancy and Childbirth|January 24, 2018
"You just need to leave the room when you breastfeed" Breastfeeding experiences among obese women in Sweden - A qualitative studyIng-Marie Claesson, Lotta Larsson, Linda Steen, et al.
Archives of Public Health = Archives Belges De Sante Publique|May 2, 2021
The physical and mental impact of surviving sepsis - a qualitative study of experiences and perceptions among a Swedish sampleSabine Apitzsch, Lotta Larsson, Anna-Karin Larsson, et al.
Arthritis Research & Therapy|June 26, 2003
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanerceptMeliha Crnkic, Bengt Månsson, Lotta Larsson, et al.
Ugeskrift for Laeger|February 7, 2007
[Treatment of rheumatoid arthritis (RA) with anti-TNF-alpha antibody (Remicade). Individual monitoring of bioavailability and immunogenicity--secondary publication]Klaus Bendtzen, Pierre Geborek, Morten Svenson, et al.
Arthritis and Rheumatism|November 30, 2006
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximabKlaus Bendtzen, Pierre Geborek, Morten Svenson, et al.
Arthritis Research & Therapy|July 28, 2006
Predictors of infusion reactions during infliximab treatment in patients with arthritisMeliha C Kapetanovic, Lotta Larsson, Lennart Truedsson, et al.
The Science of the Total Environment|June 29, 2011
Levels of brominated flame retardants and other pesistent organic pollutants in breast milk samples from Limpopo Province, South AfricaPer Ola Darnerud, Marie Aune, Lotta Larsson, et al.
Lakartidningen|October 2, 2024
[Dementia in Down syndrome]Ann-Charlotte Granholm, Lotta Larsson, Fredrik Öhman, et al.
Pageof 2